NL8402510A - Steriele, nagenoeg neutrale waterige injecteerbare suspensie. - Google Patents

Steriele, nagenoeg neutrale waterige injecteerbare suspensie. Download PDF

Info

Publication number
NL8402510A
NL8402510A NL8402510A NL8402510A NL8402510A NL 8402510 A NL8402510 A NL 8402510A NL 8402510 A NL8402510 A NL 8402510A NL 8402510 A NL8402510 A NL 8402510A NL 8402510 A NL8402510 A NL 8402510A
Authority
NL
Netherlands
Prior art keywords
particles
metronidazole
maximum size
suspension according
suspension
Prior art date
Application number
NL8402510A
Other languages
English (en)
Dutch (nl)
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of NL8402510A publication Critical patent/NL8402510A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL8402510A 1983-08-19 1984-08-15 Steriele, nagenoeg neutrale waterige injecteerbare suspensie. NL8402510A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838322364A GB8322364D0 (en) 1983-08-19 1983-08-19 Compositions of matter
GB8322364 1983-08-19

Publications (1)

Publication Number Publication Date
NL8402510A true NL8402510A (nl) 1985-03-18

Family

ID=10547557

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8402510A NL8402510A (nl) 1983-08-19 1984-08-15 Steriele, nagenoeg neutrale waterige injecteerbare suspensie.

Country Status (17)

Country Link
JP (1) JPS6067468A (sv)
AU (1) AU577055B2 (sv)
BE (1) BE900381A (sv)
CA (1) CA1214727A (sv)
CH (1) CH662812A5 (sv)
DE (1) DE3430354A1 (sv)
DK (1) DK165817C (sv)
FR (1) FR2560043B1 (sv)
GB (2) GB8322364D0 (sv)
HU (1) HU192990B (sv)
IL (1) IL72714A (sv)
IT (1) IT1213208B (sv)
LU (1) LU85511A1 (sv)
NL (1) NL8402510A (sv)
NZ (1) NZ209270A (sv)
SE (1) SE460095B (sv)
ZA (1) ZA846431B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
US7849856B2 (en) 2001-06-25 2010-12-14 3M Innovative Properties Company Respirator valve

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB213928A (en) * 1923-04-06 1925-07-02 Deutsche Werke Ag Improvements in or relating to compensated induction motors for single or polyphase alternating current
US3457348A (en) * 1966-06-27 1969-07-22 American Cyanamid Co Stable syringeable suspensions of parenteral drugs in complex floc form
GB1430411A (en) * 1973-04-05 1976-03-31 May & Baker Ltd Method and compositions for combating swine dysentery
US4029782A (en) * 1975-04-28 1977-06-14 Eli Lilly And Company Cefazolin suspension for parenteral administration
GB2000025A (en) * 1977-05-14 1979-01-04 Pfizer Ltd Nitroimidazole formulations
DE2932691A1 (de) * 1979-08-11 1981-04-09 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoeherer freisetzung der wirkstoffe

Also Published As

Publication number Publication date
IT8422323A0 (it) 1984-08-13
SE8404130L (sv) 1985-02-20
ZA846431B (en) 1985-03-27
BE900381A (fr) 1985-02-18
JPS6067468A (ja) 1985-04-17
LU85511A1 (fr) 1985-04-24
HU192990B (en) 1987-08-28
FR2560043A1 (fr) 1985-08-30
DK397084D0 (da) 1984-08-17
DK165817B (da) 1993-01-25
FR2560043B1 (fr) 1988-08-05
IT1213208B (it) 1989-12-14
SE460095B (sv) 1989-09-11
GB8322364D0 (en) 1983-09-21
NZ209270A (en) 1988-02-29
IL72714A (en) 1988-09-30
DK165817C (da) 1993-06-21
GB8420959D0 (en) 1984-09-19
GB2145088A (en) 1985-03-20
SE8404130D0 (sv) 1984-08-17
DK397084A (da) 1985-02-20
AU577055B2 (en) 1988-09-15
CH662812A5 (fr) 1987-10-30
DE3430354A1 (de) 1985-03-07
AU3202284A (en) 1985-02-21
CA1214727A (en) 1986-12-02
GB2145088B (en) 1986-10-08
HUT35650A (en) 1985-07-29

Similar Documents

Publication Publication Date Title
JP7489965B2 (ja) マルチキナーゼ阻害剤のエマルジョン製剤
US8128960B2 (en) Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
US9572887B2 (en) Formulations of bendamustine
CA2326198C (en) Cosolvent formulations
FR2853547A1 (fr) Compositions pharmaceutiques injectables contenant de la piperacilline et du tazobactame, et procede pour leur production
JP2012140451A (ja) ２，６−ジイソプロピルフェノール（プロポフォール）の水性医薬組成物およびその使用
JPS62123116A (ja) 水性液剤
JP2013231029A (ja) 既製のゲムシタビン注入溶液
DE60215129T2 (de) Esmolol-enthaltende zubereitungen
JP2006504771A (ja) システインを伴うプロポフォール
NL8402510A (nl) Steriele, nagenoeg neutrale waterige injecteerbare suspensie.
US4696814A (en) Parenteral phenytoin compositions
WO2023027670A2 (en) Lyophilized levosimendan compositions
US20160279139A1 (en) An improved process for manufacturing sterile ophthalmic pharmaceutical suspensions
JP2009102404A (ja) 予備混合アミオダロンの非経口溶液および同溶液を作製するための方法
EP2976063A1 (en) Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed